Although the overall impact of CFTR variants on chronic pancreatitis (CP) risk is more modest than earlier thought, recent large-scale cohort studies have confirmed that CFTR mutations can still play a pathogenic role. The gene discussed is CFTR; the disease is chronic pancreatitis.